# Provisional hypothesis: discordant HbA1c rise and weight trajectory and incident diabetes

## Proposed relationship
Among UK Biobank participants without diabetes at baseline, a rise in HbA1c that is discordant with the contemporaneous weight trajectory (especially weight loss or stable weight with rising HbA1c) may identify a distinct risk state for subsequent diabetes diagnosis compared with concordant HbA1c/weight change. The clinically relevant unresolved claim is whether this discordance adds information beyond baseline HbA1c, weight, BMI, and standard measured risk factors, rather than merely reflecting current glycemia or measurement timing.

## Current evidence and status
This is provisional. The parent branch identified a clinically plausible question after an earlier pancreatic endpoint failed its zero-event gate. The exact UK Biobank table/source bindings, field instances, join key/namespace, assessment-date alignment, diabetes diagnosis/date fields, and event-count/overlap audit have not yet been verified in this branch. No computed event count, prevalence estimate, or result is claimed here.

## Falsifiable test
Define a baseline cohort with valid baseline and follow-up HbA1c and weight/BMI measurements, no diabetes diagnosis at baseline, and aligned assessment dates. Compare incident diabetes diagnosis after the second assessment between (a) HbA1c rise with weight loss/stable weight and (b) HbA1c rise with weight gain, using a prespecified baseline model and a longitudinal model. The hypothesis is supported only if discordance is associated with a prespecified incremental risk beyond baseline glycemia and covariates, with uncertainty and event-support checks. It is falsified if the association disappears after date/ascertainment alignment and baseline adjustment, or if event support is too sparse to estimate the prespecified contrast. An imprecise null is inconclusive, not refutation.

## Missing evidence and stop rule
Before selection, verify: exact source paths and catalog schemas; field-instance arrays and UK Biobank ID namespace; baseline/follow-up assessment dates; diagnosis and diagnosis-date fields; exclusion of prevalent cases; and a bounded event-count/overlap audit. If diabetes events are too few, field alignment is impossible, or ascertainment cannot distinguish prevalent from incident disease, stop or narrow to a descriptive boundary test rather than claiming a causal or mechanistic result.

## Interpretation limits
Even a supportive association would not establish that weight loss causes the HbA1c rise, that discordance is mechanistic, or that intervention changes outcomes. Clinical adjudication, medication/treatment data, and external validation would be required for stronger conclusions.
